Sirolimus balloon for non-blocking heart plaques
Part of Heart & circulation clinical trials.
This study tests if a special balloon coated with sirolimus can help stabilize or shrink non-blocking plaques in your heart arteries after a recent heart attack. You may be eligible if you've had a heart attack in the past 3 months and have at least two non-blocking plaques in different arteries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a heart attack or unstable angina within the last 3 months and treatment for the main blockage was successful.
- You have at least two non-blocking plaques in different heart arteries that are not the main cause of your recent event.
- These plaques were measured by a special imaging test (IVUS or NIRS) and found to have a certain amount of fatty buildup.
- You are 18 years or older.
- You are willing and able to give written consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new balloon coated with sirolimus (a drug that helps prevent re-blockage) for treating blocked arteries at branch points (bifurcations) in the heart. If you have a blocked artery at a branch point, this study may offer a way to treat the side branch without placing a stent there.
This study tests a special balloon coated with a drug called sirolimus to open blocked heart arteries. It may be an option for people with coronary artery disease who need a less invasive treatment.
This study tests a special balloon coated with a medicine (Biolimus) to open new blockages in large heart arteries. The goal is to see if it works well as an alternative to a stent for people with certain blockages.
This trial compares two types of special balloons coated with different medications to treat blocked heart arteries in patients with acute heart attacks. The goal is to see which coating works better to keep the artery open and prevent future blockages.
This trial tests a new drug-coated balloon (Genoss SCB) versus an existing one (SeQuent Please NEO) for people whose heart stents have re-narrowed. It aims to see which balloon better keeps the artery open.
This trial is comparing sirolimus and paclitaxel drug-coated balloons to treat new blockages or restenosis (re-blockage) in heart arteries. It aims to see which type of balloon works better for opening arteries without leaving a metal stent behind.
Hear when a new Coronary Arterial Disease (CAD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.